
The Kennedy Trust funds a number of additional projects in the fields of musculoskeletal and inflammatory disease research, independent of our established funding schemes.
We consider informal approaches from, and offer support to, institutions only; we do not consider personal applications.
Some examples of the additional projects we fund are outlined below.


MusculoskelEtal faTigue acRoss the lIfe CourSe: understanding what helps and mapping what is missing (METRICS)
The Kennedy Trust has partnered with Versus Arthritis to fund a comprehensive scoping review on the ways of measuring, assessing and treating severe fatigue associated with rheumatic and related musculoskeletal disorders. The review will be carried out by Assistant Professor Emma Dures and her team at the University of the West of England over 12 months from August 2023.
By generating evidence on existing fatigue management and mapping crucial areas of unmet need, it is hoped that the project will provide an important guide for future research in the area.


Treating obesity-induced osteoarthritis with Agrin
In collaboration with the Medical Research Council, the Kennedy Trust has awarded Dr Scerif a three-year Daphne Jackson Fellowship to support her return to scientific research after a six-year career break. She previously obtained a master’s degree from Queen Mary University of London, before completing a PhD at University College London.
Dr Scerif’s research explores the use of Agrin to promote cartilage formation in the treatment of obesity-induced osteoarthritis.


Synovial lymphocyte diversity and origin in childhood onset arthritis
In collaboration with the Medical Research Council, the Kennedy Trust has awarded Dr Clay a three-year Daphne Jackson Fellowship to support her return to scientific research after a four-year career break. She previously completed both her master’s degree and PhD at the University of Birmingham.
Dr Clay’s study will investigate what cells are present in the tissue of joints of children with arthritis and whether these cells can predict later disease outcomes.